Navigation Links
VAD in Medical News

WorldHeart Submits IDE Application for a Pivotal Bridge-to-Transplant Study of the Levacor(TM) VAD

OAKLAND, Calif., Jan. 8 /PRNewswire-FirstCall/ -- (Nasdaq: WHRT ) World Heart Corporation ("WorldHeart") announced today that it has submitted an Investigational Device Exemption ("IDE") application to the US Food and Drug Administration ("FDA" or the "Agency") for a pivotal Bridge-to-Transpla...

Thoratec Corporation and HeartWare International, Inc. Announce Termination of Proposed Transaction

...on Thoratec Corporation is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate LVAS, with more than 13,000 devices implanted in patients suffering from heart failure. Additionally, its In...

Thoratec Schedules Second Quarter Conference Call, Webcast

... Thoratec Corporation is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System), with more than 13,000 devices implanted in patients suffering from...

AGH Joins Select Group of Medical Centers in Study of Promising New Technology for Treatment of Heart Failure

...Commission’s newly required Disease Specific vad Certification. In the first four months of 2009 a...ne, the hospital’s medical team performed 18 vad implants and is actively involved in several state-of-the-art vad clinical trials for both destination (or permanent...

Thoratec Announces Appointment of Paul LaViolette to Board of Directors

... Thoratec Corporation is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System), with more than 13,000 devices implanted in patients suffering from...

Thoratec Presentation at JMP Securities Conference to be Webcast

...oratec.com . Thoratec is world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System) with more than 13,000 devices implanted in patients suffering from ...

Thoratec Schedules First Quarter Conference Call, Webcast

... Thoratec Corporation is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System), with more than 13,000 devices implanted in patients suffering from...

Hahnemann University Hospital Awarded Certification From the Joint Commission for Ventricular Assist Devices

...ients either await a heart transplant, or for destination therapy when transplant is not a viable option. "Hahnemann sought accreditation for our vad program because we wanted to demonstrate our commitment to our patients' safety and quality care," said George Amrom, M.D ., chief medical officer of...

Artificial pump effectively backs up failing hearts

... the trial included stroke and bleeding, and the number and type of adverse events was similar to other LVADs but better than that of first-generation vad devices. Answering standardized questionnaires for patients with heart failure, they reported a significantly improved quality of life after receiv...

Thoratec and HeartWare Receive Request for Additional Information From Federal Trade Commission

...atec Corporation Thoratec is a leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System) with more than 12,000 devices implanted in patients suffering from ...

More>>

VAD in Medical Technology

Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients

...splantation." VELCADE-Dexamethasone versus vad as Induction Treatment Prior to ASCT in Newly Diag...he VcD arm, compared with 60 percent in the vad arm (p=0.0115). -- Post-induction complete res...the VcD arm, compared with 7 percent in the vad arm (p=0.0035). -- After the first performed A...

Thoratec Says Interim Data Analysis Demonstrates Statistical Superiority for the HeartMate II(R) in Destination Therapy Trial

... quietly. Thoratec is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate LVAS with more than 12,000 devices implanted in patients suffering from heart failure. Additionally, its Int...

First U.S. Patient to Receive New Heart-Assist Device Doing Well After Surgery at University of Michigan

...e common enough that hospitals can now apply for accreditation as certified vad centers, an indication of their experience in implanting the devices and ta... their device. This spring, U-M became one of the first few such accredited vad centers in the nation. The DuraHeart was invented and developed by a team...

VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma

...inical trial were presented by Professor Harousseau. The VcD arm versus the vad arm showed: -- 95 percent of patients were alive at one year compared...nd on days 9 through 12 during cycles one and two only. The patients in the vad arm were treated for four 28-day cycles with vincristine at 0.4 mg/m2 on da...

New Data to Support VELCADE(R) (Bortezomib) For Injection Based Therapies as Setting New Standards in The Care of Newly Diagnosed Patients With Multiple Myeloma

...Universitario de Salamanca - Abstract #76: Oral presentation session: Sunday 9 December, 4:30 p.m. -- VELCADE Dexamethasone (VEL/D) versus vad as Induction Treatment Prior to Autologous Stem Cell Transplantation (ASCT) in Newly Diagnosed Multiple Myeloma - Lead investigator: Jean-...

WorldHeart Announces Further Milestone in Miniaturized Assist Pump Development

...evacor(TM) VAD, is being extended to the pediatric vad and then potentially to a WorldHeart minimally inv...ty-phase bridge-to-transplant study of the Levacor vad is planned to begin in late 2007 or early 2008. Wo...rotocol for the upcoming study. About the Levacor vad The Levacor is a next-generation rotary VAD. It i...

Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival

...mpare VELCADE in combination with dexamethasone to vad as induction therapy prior to SCT in 480 newly dia...onse + CR (VGPR + CR) rate of 75 percent. vad showed a CR rate of 28 percent and a VGPR + CR ...ugh 12 during cycles one and two only. Patients on vad were treated for four cycles with vincristine at 0...
VAD in Biological Technology

The Modern DeBakey VAD™ To Be Introduced For the First Time in the U.S. : HeartAssist 5™ Pediatric VAD Features Industry Exclusive Direct Blood Flow Measurement System

The HeartAssist 5™ Pediatric VAD will be introduced for the first time in the U.S. at the 16th annual meeting of the International Society for Rotary Blood Pumps (ISRBP) in Houston on Oct. 2-4. HOUSTON (Business Wire EON) September 30, 2008 -- The Modern DeBakey...

Berlin Heart Enrolls First Patient in US Multi-Center EXCOR(R) Pediatric VAD IDE Study

BERLIN, November 30 /PRNewswire/ -- Berlin Heart today announced the first patient enrolment in the prospective IDE study for its EXCOR(R) Paediatric VAD, a mechanical cardiac support system for critically ill Paediatric patients suffering from severe heart failure. The multi-center IDE stud...

U.S. Federal Trade Commission to Challenge Thoratec's Proposed Acquisition of HeartWare International

...on Thoratec Corporation is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate LVAS, with more than 13,000 devices implanted in patients suffering from heart failure. Additionally, its In...

Berlin Heart Inc. Receives FDA Orphan Product Development Grant

... the grant project "Safety and Efficacy of the Berlin Heart EXCOR Pediatric vad as a Bridge to Heart Transplantation." The Berlin Heart EXCOR Pediatric vad is a system for mechanical support of the heart in end-stage heart failure ...

Thoratec Announces Filing of PMA Seeking Destination Therapy Approval for HeartMate II(R)

...tile device. Thoratec is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate LVAS with more than 13,000 devices implanted in patients suffering from heart failure. Additionally, its Int...

Thoratec Presentation at J.P. Morgan Conference to be Webcast

...tec.com . Thoratec is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System) with nearly 12,000 devices implanted in patients suffering from hea...

Thoratec Reports 44 Percent Increase in Third Quarter Revenues

...cial measures. Thoratec is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad and HeartMate LVAS with nearly 12,000 devices implanted in patients suffering from heart failure. Additionally, its International Technidyne Corporati...

Thoratec Schedules Third Quarter 2008 Conference Call, Webcast

...53. Thoratec Corporation is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System) with nearly 12,000 devices implanted in patients suffering from hea...

Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History

... passcode 4229045. Thoratec is a world leader in therapies to address advanced stage heart failure. The company's product lines include the Thoratec vad and HeartMate LVAS with more than 11,000 devices implanted in patients suffering from heart failure. Additionally, its International Technidyne Corpor...

Thoratec Announces Appointment of Steven H. Collis to Board of Directors

...ld leader in hemodynamic restoration therapy- developing products to treat cardiovascular disease. The company's product line includes the Thoratec(R) vad (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System) with more than 11,000 devices implanted in patients suffering from ...
Other Tags
(Date:7/30/2015)... New York, NY (PRWEB) , ... July 30, ... ... with Setria®Glutathione and Sustamine® L-Alanyl-L-Glutamine for people on the go. With no water ... Zaca Recovery Chewable as a simple way to get the natural ingredients that ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... ... TikiLIVE, has worked to protect victims in San Diego, California’s Gaslamp Quarter Plaza ... used by Gaslamp Quarter Plaza actively monitor the area for any suspicious activity. ...
(Date:7/30/2015)... ... July 30, 2015 , ... The American Telemedicine Association (ATA) ... Tradeshow focused exclusively on telemedicine, telehealth and mHealth. The meeting, expected to attract ... take place May 14-17, 2016 in Minneapolis, MN. , ATA’s annual meeting attracts ...
(Date:7/30/2015)... ... 30, 2015 , ... Well-known San Diego AC, plumbing and ... cost service and repair companies. For 35 years, they have grown both their ... to meet the demands of the changing technological environment. , To ...
(Date:7/30/2015)... Orange County, CA (PRWEB) , ... July 30, ... ... of home health care throughout Orange, Riverside, Los Angeles, and San Bernardino counties, ... team as the new Palliative Care Administrator. Dr. Demoratz is a strong proponent ...
Breaking Medicine News(10 mins):Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 2Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 3Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 4Health News:Eyepartner Software Helps Victims in Gaslamp Quarter Plaza 2Health News:Eyepartner Software Helps Victims in Gaslamp Quarter Plaza 3Health News:Presentation Proposals for ATA 2016 are Now Being Accepted Online at ATA2016.com 2Health News:Presentation Proposals for ATA 2016 are Now Being Accepted Online at ATA2016.com 3Health News:Bill Howe Plumbing, Heating & Air Launches Online Application to Prospective Employees 2Health News:Bill Howe Plumbing, Heating & Air Launches Online Application to Prospective Employees 3Health News:24/7 Care At Home Welcomes Michael Demoratz, PhD, LCSW, CCM as New Palliative Care Administrator 2Health News:24/7 Care At Home Welcomes Michael Demoratz, PhD, LCSW, CCM as New Palliative Care Administrator 3
(Date:7/27/2015)... July 27, 2015  Synaptics Inc. (NASDAQ: ... solutions, today announced that Huawei has selected the ... for its stylish smartwatch. Huawei chose the state-of-the-art ... low power and highly responsive human interface qualities ... designers also required a classic round watch face ...
(Date:7/21/2015)... 21, 2015 Today, ZTE announced its Android ... well as expected revenues in 2015 that relate to sales of ... guidance of approximately 2,200 MSEK for 2015. Jörgen Lantto, ... smartphone manufacturer in China and we are ... 5 for Axon , its ...
(Date:7/13/2015)... , July 13, 2015 Synaptics ... of human interface solutions, today announced sampling of ... and display driver integration (TDDI) product targeting smartphones ... first to combine Synaptics , best-in-class touch ... display driver technology developed in the company,s Japan ...
Breaking Biology News(10 mins):Synaptics Touchscreen Solution Powers New Huawei Watch 2Synaptics Touchscreen Solution Powers New Huawei Watch 3FPC's Touch Fingerprint Sensor FPC1025 in ZTE's Smartphone Axon 2Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3
Other Contents